Order Article Reprints

Thomford NE, Awortwe C, Dzobo K, Adu F, Chopera D, Wonkam A, Skelton M, Blackhurst D, Dandara C. Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings. Molecules. 2016; 21(2):211. https://doi.org/10.3390/molecules21020211

Thomford, Nicholas E., Charles Awortwe, Kevin Dzobo, Faustina Adu, Denis Chopera, Ambroise Wonkam, Michelle Skelton, Dee Blackhurst, and Collet Dandara. 2016. "Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings" Molecules 21, no. 2: 211. https://doi.org/10.3390/molecules21020211

Thomford, N. E., Awortwe, C., Dzobo, K., Adu, F., Chopera, D., Wonkam, A., Skelton, M., Blackhurst, D., & Dandara, C. (2016). Inhibition of CYP2B6 by Medicinal Plant Extracts: Implication for Use of Efavirenz and Nevirapine-Based Highly Active Anti-Retroviral Therapy (HAART) in Resource-Limited Settings. Molecules, 21(2), 211. https://doi.org/10.3390/molecules21020211